Ixazomib-induced cutaneous necrotizing vasculitis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/article/10.1007/s00520-018-4052-1/fulltext.html
Reference11 articles.
1. Kupperman E, Lee EC, Cao Y et al (2010) Evaluation of the proteasome inhibitor MLN9708 in preclinical models of human cancer. Cancer Res 70(5):1970–1980
2. Agterof MJ, Biesma DH (2005) Images in clinical Medicine. Bortezomib-induced skin lesions. N Engl J Med 352(24):2534
3. Min CK, Lee S, Kim YJ (2006) Cutaneous leucoclastic vasculitis (LV) following bortezomib therapy in a myeloma patient; association with pro-inflammatory cytokines. Eur J Haematol 76(3):265–268
4. Garcia-Navarro X, Puig L, Fernandez-Figueras MT, Dalmau J, Roe E, Alomar A (2007) Bortezomib-associated cutaneous vasculitis. Br J Dermatol 157(4):799–801. https://doi.org/10.1111/j.1365-2133.2007.08073.x
5. Kumar SK, Berdeja JG, Niesvizky R, Lonial S, Laubach JP, Hamadani M, Stewart AK, Hari P, Roy V, Vescio R, Kaufman JL, Berg D, Liao E, di Bacco A, Estevam J, Gupta N, Hui AM, Rajkumar V, Richardson PG (2014) Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study. Lancet Oncol 15(13):1503–1512. https://doi.org/10.1016/S1470-2045(14)71125-8
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia;Hematology/Oncology Clinics of North America;2023-08
2. A Spotlight on Drug-Induced Vasculitis;Current Rheumatology Reports;2022-09-21
3. Drug-Induced Vasculitis;Drug Eruptions;2022
4. T‐cell pseudolymphoma secondary to ixazomib for multiple myeloma;Skin Health and Disease;2021-06-30
5. Dermatologic Adverse Effects of Anticancer Therapy III: Targeted and Immunotherapies;Dermato-Oncology Study Guide;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3